在大量方便抽样的大麻使用者中探索大麻对酒精和其他药物的替代作用。

IF 4 2区 社会学 Q1 SUBSTANCE ABUSE
Chris Wilkins, Jose Romeo, Marta Rychert, Thomas Graydon-Guy
{"title":"在大量方便抽样的大麻使用者中探索大麻对酒精和其他药物的替代作用。","authors":"Chris Wilkins, Jose Romeo, Marta Rychert, Thomas Graydon-Guy","doi":"10.1186/s12954-024-01111-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed evidence with recent reviews suggesting cannabis co-use patterns may vary by age and ethnicity. Yet few studies have had large enough samples to examine this demographic variation in detail.</p><p><strong>Aims: </strong>To explore the co-use of cannabis with alcohol and other drugs within demographic subgroups of a large sample of people who use cannabis. Specifically: (1) whether cannabis is being substituted for other drugs, and (2), whether cannabis use leads to more, less or the same level of other drug use.</p><p><strong>Method: </strong>Online convenience survey promoted via Facebook™ completed by 23,500 New Zealand respondents. Those who had used cannabis and any of eight other substances in the same six-month period were asked if their use of cannabis had any impact on their use of each other substance (\"a lot more\", \"little more\", \"no impact/same\", \"little less\", \"a lot less\"). Frequency and quantity used of each other drug was compared by co-use group. Generalised logistic regression models were developed to predict co-use categories.</p><p><strong>Results: </strong>Significant proportions reported cannabis use led to \"less\" alcohol (60%), synthetic cannabinoid (60%), morphine (44%) and methamphetamine (40%) use. Those who reported using \"less\" had lower frequency and amount used of other drugs. Approximately seven-out-ten reported cannabis use had \"no impact\" on LSD, MDMA, and cocaine use. One-in-five reported using cannabis led to \"more\" tobacco use. Young adults (21-35-years) were more likely to report cannabis use led to \"less\" drinking and methamphetamine use. Adolescent co-users (16-20 years) reported mixed impacts. Māori were more likely to report cannabis use resulted in \"less\" alcohol, tobacco, methamphetamine, and LSD use. Students and those living in cities were less likely to report cannabis use lowering use of other substances.</p><p><strong>Conclusion: </strong>Cannabis and other drug co-use patterns are moderated by life stages, lifestyles, cultural perspectives, and urbanicity. Harm reduction initiatives and policy reforms should take account of these moderating factors.</p>","PeriodicalId":12922,"journal":{"name":"Harm Reduction Journal","volume":null,"pages":null},"PeriodicalIF":4.0000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536895/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the substitution of cannabis for alcohol and other drugs among a large convenience sample of people who use cannabis.\",\"authors\":\"Chris Wilkins, Jose Romeo, Marta Rychert, Thomas Graydon-Guy\",\"doi\":\"10.1186/s12954-024-01111-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed evidence with recent reviews suggesting cannabis co-use patterns may vary by age and ethnicity. Yet few studies have had large enough samples to examine this demographic variation in detail.</p><p><strong>Aims: </strong>To explore the co-use of cannabis with alcohol and other drugs within demographic subgroups of a large sample of people who use cannabis. Specifically: (1) whether cannabis is being substituted for other drugs, and (2), whether cannabis use leads to more, less or the same level of other drug use.</p><p><strong>Method: </strong>Online convenience survey promoted via Facebook™ completed by 23,500 New Zealand respondents. Those who had used cannabis and any of eight other substances in the same six-month period were asked if their use of cannabis had any impact on their use of each other substance (\\\"a lot more\\\", \\\"little more\\\", \\\"no impact/same\\\", \\\"little less\\\", \\\"a lot less\\\"). Frequency and quantity used of each other drug was compared by co-use group. Generalised logistic regression models were developed to predict co-use categories.</p><p><strong>Results: </strong>Significant proportions reported cannabis use led to \\\"less\\\" alcohol (60%), synthetic cannabinoid (60%), morphine (44%) and methamphetamine (40%) use. Those who reported using \\\"less\\\" had lower frequency and amount used of other drugs. Approximately seven-out-ten reported cannabis use had \\\"no impact\\\" on LSD, MDMA, and cocaine use. One-in-five reported using cannabis led to \\\"more\\\" tobacco use. Young adults (21-35-years) were more likely to report cannabis use led to \\\"less\\\" drinking and methamphetamine use. Adolescent co-users (16-20 years) reported mixed impacts. Māori were more likely to report cannabis use resulted in \\\"less\\\" alcohol, tobacco, methamphetamine, and LSD use. Students and those living in cities were less likely to report cannabis use lowering use of other substances.</p><p><strong>Conclusion: </strong>Cannabis and other drug co-use patterns are moderated by life stages, lifestyles, cultural perspectives, and urbanicity. Harm reduction initiatives and policy reforms should take account of these moderating factors.</p>\",\"PeriodicalId\":12922,\"journal\":{\"name\":\"Harm Reduction Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2024-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11536895/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Harm Reduction Journal\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.1186/s12954-024-01111-w\",\"RegionNum\":2,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harm Reduction Journal","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1186/s12954-024-01111-w","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0

摘要

背景:大麻替代酒精和其他药物的概念是在一个减少危害的框架内提出的,即使用大麻来减少其他药物的负面副作用、成瘾可能性和社会耻辱感。目前的证据参差不齐,最近的评论表明,大麻的共同使用模式可能因年龄和种族而异。目的:探讨在大量大麻使用者样本的人口亚群中,大麻与酒精和其他药物的共同使用情况。具体来说:(1) 大麻是否被其他药物所替代,(2) 使用大麻是否会导致更多、更少或同等程度的其他药物使用:方法:通过 Facebook™ 推广的在线便利调查,由 23,500 名新西兰受访者完成。调查询问那些在同一六个月内使用过大麻和其他八种药物中的任何一种的受访者,使用大麻是否会对他们使用其他每种药物产生任何影响("多很多"、"多一点"、"无影响/相同"、"少一点"、"少很多")。按共同使用组别对其他每种药物的使用频率和数量进行了比较。建立了广义逻辑回归模型来预测共同使用药物的类别:有相当大比例的人报告称,吸食大麻导致 "较少 "使用酒精(60%)、合成大麻素(60%)、吗啡(44%)和甲基苯丙胺(40%)。报告使用 "较少 "的人使用其他药物的频率和数量都较低。大约十分之七的人报告说吸食大麻对迷幻药、摇头丸和可卡因的使用 "没有影响"。五分之一的人报告使用大麻导致 "更多 "使用烟草。青壮年(21-35 岁)更有可能报告使用大麻导致 "减少 "饮酒和使用甲基苯丙胺。青少年共同使用者(16-20 岁)报告的影响不一。毛利人更有可能报告使用大麻导致 "较少 "使用酒精、烟草、甲基苯丙胺和迷幻剂。学生和居住在城市的人较少报告吸食大麻会降低其他药物的使用:大麻和其他药物的共同使用模式受人生阶段、生活方式、文化观点和城市化程度的影响。减少危害倡议和政策改革应考虑到这些调节因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the substitution of cannabis for alcohol and other drugs among a large convenience sample of people who use cannabis.

Background: The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed evidence with recent reviews suggesting cannabis co-use patterns may vary by age and ethnicity. Yet few studies have had large enough samples to examine this demographic variation in detail.

Aims: To explore the co-use of cannabis with alcohol and other drugs within demographic subgroups of a large sample of people who use cannabis. Specifically: (1) whether cannabis is being substituted for other drugs, and (2), whether cannabis use leads to more, less or the same level of other drug use.

Method: Online convenience survey promoted via Facebook™ completed by 23,500 New Zealand respondents. Those who had used cannabis and any of eight other substances in the same six-month period were asked if their use of cannabis had any impact on their use of each other substance ("a lot more", "little more", "no impact/same", "little less", "a lot less"). Frequency and quantity used of each other drug was compared by co-use group. Generalised logistic regression models were developed to predict co-use categories.

Results: Significant proportions reported cannabis use led to "less" alcohol (60%), synthetic cannabinoid (60%), morphine (44%) and methamphetamine (40%) use. Those who reported using "less" had lower frequency and amount used of other drugs. Approximately seven-out-ten reported cannabis use had "no impact" on LSD, MDMA, and cocaine use. One-in-five reported using cannabis led to "more" tobacco use. Young adults (21-35-years) were more likely to report cannabis use led to "less" drinking and methamphetamine use. Adolescent co-users (16-20 years) reported mixed impacts. Māori were more likely to report cannabis use resulted in "less" alcohol, tobacco, methamphetamine, and LSD use. Students and those living in cities were less likely to report cannabis use lowering use of other substances.

Conclusion: Cannabis and other drug co-use patterns are moderated by life stages, lifestyles, cultural perspectives, and urbanicity. Harm reduction initiatives and policy reforms should take account of these moderating factors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Harm Reduction Journal
Harm Reduction Journal Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.90
自引率
9.10%
发文量
126
审稿时长
26 weeks
期刊介绍: Harm Reduction Journal is an Open Access, peer-reviewed, online journal whose focus is on the prevalent patterns of psychoactive drug use, the public policies meant to control them, and the search for effective methods of reducing the adverse medical, public health, and social consequences associated with both drugs and drug policies. We define "harm reduction" as "policies and programs which aim to reduce the health, social, and economic costs of legal and illegal psychoactive drug use without necessarily reducing drug consumption". We are especially interested in studies of the evolving patterns of drug use around the world, their implications for the spread of HIV/AIDS and other blood-borne pathogens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信